Studies

New Breathe finds the best specialist in your pathology so that you can ask for a second opinion. In addition, it helps you find a clinical trial that meets all the requirements, being able to accompany you and take care of all the bureaucratic part of the process.

Breast Cancer


Breast cancer is the most common type of cancer among women and is the second leading cause of cancer death in women.
About 10% of all cases of breast cancer are related to genetic predisposition or family history, with variances by country and ethnicity.

Despite being rare, breast cancer also affects men, in Portugal, about 1% of breast cancers are in men.
Over the years, there has been a continuous investigation: new data are discovered about its causes and new ways of preventing, detecting and treating. All work with the objective of improving the quality of life, chances of cure, and how to diminish the psychological and social burden of this disease.
Future research in breast cancer will focus not only on new drugs, but even more on the individualization of therapy for every single tumor in every single patient.


MORE INFORMATION

Parkinson’s disease


Parkinson’s disease is considered the second most common degenerative disease of the central nervous system. It is a rare disease among children and adolescents, being common between 50 and 79 years old, and with prevalence in men. It is estimated that there are about 7 to 10 million individuals with the disease, with about 5% of cases appearing before the age of 40.

Parkinson’s disease is a degenerative and slowly progressive disease of specific areas of the brain. It is characterized by tremor when the muscles are at rest, increased muscular stiffness, postural instability. In many people, thinking becomes compromised or dementia develops.

Current scientific research is focused on identifying potential biomarkers of the disease, which allow an accurate and timely diagnosis, and on the creation of more effective therapies, in order to fill the currently unmet clinical needs.


MORE INFORMATION



Colorectal cancer


The colorectal cancer (CRC) is the second leading cause of death by cancer in the Western world. Combined, in both sexes, colorectal cancer is the third-most common cancer and accounts for 9.7% of all cancers excluding non-melanoma skin cancer. More than half of the cases occur in more-developed regions of world. The majority of patients with sporadic cancer are >50 years of age, with 75% of patients with rectal cancer and 80% of patients with colon cancer patients being ≥60 years of age at the time of diagnosis.

Based on current incidence and mortality rates as well as on projected demographic changes in the world population for the coming decades, the World Health Organization (WHO) estimates an increase of 77% in the number of newly diagnosed CRC cases and an increase of 80% in deaths from CRC by 2030.
The recent advances in molecular biology and the genetic classification of CRC are essential to individualize these therapies and will be basic for improving the treatment in the next years.


MORE INFORMATION

Alzheimer’s Disease


Alzheimer’s disease is the most common form of dementia, causing a global, progressive and irreversible deterioration of several cognitive functions, including memory, attention, concentration, language and thinking.

According to the World Health Organization, about 60 to 70% of all cases of dementia belong to Alzheimer’s disease.

There are an estimated 193,000 Alzheimer’s patients in Europe, with 47.5 million cases of dementia.

So far there is no cure for this disease. However, there are some medications that help stabilize cognitive functions in people in the mild to moderate stages.


MORE INFORMATION



Leukemia


Leukemia is a cancer of the most primitive cells in the bone marrow, the stem cells. Bone marrow is the organ where the cells of the blood, the mature cells, are formed. These cells form from stem cells, which are more primitive.

The main leukemias are:
-Acute lymphoblastic leukemia (ALL) – is the most common type of leukemia in pediatric age. ALL starts in the bone marrow, and most of the time, the leukemic cells invade the blood fairly quickly but can also spread to other parts of the body. 
-Acute myeloid leukemia (AML) – affects both adults and children. It results from the malignant transformation and uncontrolled proliferation of an abnormally differentiated long-lived myeloid progenitor cell resulting in high circulating numbers of immature blood cells and replacement of the bone marrow with malignant cells.
-Chronic lymphoid leukemia (CLL) – mainly affects adultos mais velhos e é responsável por cerca de um terço de todas as leucemias. It is a type of leukemia that starts in the white blood cells in the bone marrow.
-Chronic myeloid leukemia (CML) – mainly affects adults and does not affect children. Occurs when the pluripotent stem cell undergoes malignant transformation and clonal myeloproliferation, causing overproduction of immature granulocytes.


MORE INFORMATION

Skin Cancer


The skin is our biggest organ and its cells renew in a regular and controlled way. Every day, skin cells age and die and are replaced by new cells. Sometimes this systematic process goes wrong, with new cells forming without the skin needing them, and without aging cells dying when they should. This excess of cells can form a mass of tissue called a neoplasm or tumor.

The two most common types of nonmelanoma skin cancer are basal cell carcinoma and squamous cell carcinoma. This type of carcinoma represents, together, about 90% of all skin neoplasms and tend to appear on the head, face, neck, hands and arms, the areas most exposed to the sun. However, skin cancer can appear anywhere on the body.

There are currently several new oncologic medical therapies that have shown very promising results in the treatment of advanced melanomas.


MORE INFORMATION



Lung Cancer


Lung cancer is the leading cause of cancer death in the United States and around the world. Almost as many Americans die of lung cancer every year as die of prostate, breast, and colon cancer combined.
Lung cancer tumors are divided into two broad histological categories: non-small cell lung carcinoma (NSCLC) and small-cell lung carcinoma (SCLC). NSCLC represents more than 80 to 85% of lung cancers of which approximately 40% are adenocarcinoma, 25 to 30% are squamous cell carcinoma, and 10 to 15% are large cell carcinomas.

The geographic and temporal patterns of lung cancer incidence, as well as lung cancer mortality, on a population level are mainly determined by tobacco consumption, the main aetiological factor in lung carcinogenesis. Other factors such as genetic susceptibility, poor diet, occupational exposures and air pollution may act independently or in concert with tobacco smoking in the pathofisiology of lung cancer.


MORE INFORMATION

Biliary Tract Cancer


Biliary tract cancer or cholangiocarcinoma is one of the types of cancer of the digestive system and is also one of the types of hepatobiliopancreatic tumors (liver, pancreas, and bile ducts). It occurs mainly in people over 50 years of age, although it can occur at any age.

Cancer can develop anywhere in the bile duct and, based on its location, is classified into three types:

  • Intrahepatic cholangiocarcinoma;
  • Perihilar cholangiocarcinoma: Being the most common type of cholangiocarcinoma, accounting for more than half of all cancers of the bile duct;
  • Distal cholangiocarcinoma;

MORE INFORMATION




Breast Cancer


Breast cancer is the most common type of cancer among women and is the second leading cause of cancer death in women.
About 10% of all cases of breast cancer are related to genetic predisposition or family history, with variances by country and ethnicity.

Despite being rare, breast cancer also affects men, in Portugal, about 1% of breast cancers are in men.
Over the years, there has been a continuous investigation: new data are discovered about its causes and new ways of preventing, detecting and treating. All work with the objective of improving the quality of life, chances of cure, and how to diminish the psychological and social burden of this disease.
Future research in breast cancer will focus not only on new drugs, but even more on the individualization of therapy for every single tumor in every single patient.


MORE INFORMATION


Parkinson’s disease


Parkinson’s disease is considered the second most common degenerative disease of the central nervous system. It is a rare disease among children and adolescents, being common between 50 and 79 years old, and with prevalence in men. It is estimated that there are about 7 to 10 million individuals with the disease, with about 5% of cases appearing before the age of 40.

Parkinson’s disease is a degenerative and slowly progressive disease of specific areas of the brain. It is characterized by tremor when the muscles are at rest, increased muscular stiffness, postural instability. In many people, thinking becomes compromised or dementia develops.

Current scientific research is focused on identifying potential biomarkers of the disease, which allow an accurate and timely diagnosis, and on the creation of more effective therapies, in order to fill the currently unmet clinical needs.


MORE INFORMATION


Colorectal cancer


The colorectal cancer (CRC) is the second leading cause of death by cancer in the Western world. Combined, in both sexes, colorectal cancer is the third-most common cancer and accounts for 9.7% of all cancers excluding non-melanoma skin cancer. More than half of the cases occur in more-developed regions of world. The majority of patients with sporadic cancer are >50 years of age, with 75% of patients with rectal cancer and 80% of patients with colon cancer patients being ≥60 years of age at the time of diagnosis.

Based on current incidence and mortality rates as well as on projected demographic changes in the world population for the coming decades, the World Health Organization (WHO) estimates an increase of 77% in the number of newly diagnosed CRC cases and an increase of 80% in deaths from CRC by 2030.
The recent advances in molecular biology and the genetic classification of CRC are essential to individualize these therapies and will be basic for improving the treatment in the next years.


MORE INFORMATION


Alzheimer’s Disease


Alzheimer’s disease is the most common form of dementia, causing a global, progressive and irreversible deterioration of several cognitive functions, including memory, attention, concentration, language and thinking.

According to the World Health Organization, about 60 to 70% of all cases of dementia belong to Alzheimer’s disease.

There are an estimated 193,000 Alzheimer’s patients in Europe, with 47.5 million cases of dementia.

So far there is no cure for this disease. However, there are some medications that help stabilize cognitive functions in people in the mild to moderate stages.


MORE INFORMATION


Leukemia


Leukemia is a cancer of the most primitive cells in the bone marrow, the stem cells. Bone marrow is the organ where the cells of the blood, the mature cells, are formed. These cells form from stem cells, which are more primitive.

The main leukemias are:
-Acute lymphoblastic leukemia (ALL) – is the most common type of leukemia in pediatric age. ALL starts in the bone marrow, and most of the time, the leukemic cells invade the blood fairly quickly but can also spread to other parts of the body. 
-Acute myeloid leukemia (AML) – affects both adults and children. It results from the malignant transformation and uncontrolled proliferation of an abnormally differentiated long-lived myeloid progenitor cell resulting in high circulating numbers of immature blood cells and replacement of the bone marrow with malignant cells.
-Chronic lymphoid leukemia (CLL) – mainly affects adultos mais velhos e é responsável por cerca de um terço de todas as leucemias. It is a type of leukemia that starts in the white blood cells in the bone marrow.
-Chronic myeloid leukemia (CML) – mainly affects adults and does not affect children. Occurs when the pluripotent stem cell undergoes malignant transformation and clonal myeloproliferation, causing overproduction of immature granulocytes.


MORE INFORMATION


Skin Cancer


The skin is our biggest organ and its cells renew in a regular and controlled way. Every day, skin cells age and die and are replaced by new cells. Sometimes this systematic process goes wrong, with new cells forming without the skin needing them, and without aging cells dying when they should. This excess of cells can form a mass of tissue called a neoplasm or tumor.

The two most common types of nonmelanoma skin cancer are basal cell carcinoma and squamous cell carcinoma. This type of carcinoma represents, together, about 90% of all skin neoplasms and tend to appear on the head, face, neck, hands and arms, the areas most exposed to the sun. However, skin cancer can appear anywhere on the body.

There are currently several new oncologic medical therapies that have shown very promising results in the treatment of advanced melanomas.


MORE INFORMATION


Lung Cancer


Lung cancer is the leading cause of cancer death in the United States and around the world. Almost as many Americans die of lung cancer every year as die of prostate, breast, and colon cancer combined.
Lung cancer tumors are divided into two broad histological categories: non-small cell lung carcinoma (NSCLC) and small-cell lung carcinoma (SCLC). NSCLC represents more than 80 to 85% of lung cancers of which approximately 40% are adenocarcinoma, 25 to 30% are squamous cell carcinoma, and 10 to 15% are large cell carcinomas.

The geographic and temporal patterns of lung cancer incidence, as well as lung cancer mortality, on a population level are mainly determined by tobacco consumption, the main aetiological factor in lung carcinogenesis. Other factors such as genetic susceptibility, poor diet, occupational exposures and air pollution may act independently or in concert with tobacco smoking in the pathofisiology of lung cancer.


MORE INFORMATION


Biliary Tract Cancer


Biliary tract cancer or cholangiocarcinoma is one of the types of cancer of the digestive system and is also one of the types of hepatobiliopancreatic tumors (liver, pancreas, and bile ducts). It occurs mainly in people over 50 years of age, although it can occur at any age.
Cancer can develop anywhere in the bile duct and, based on its location, is classified into three types:
  • Intrahepatic cholangiocarcinoma;
  • Perihilar cholangiocarcinoma: Being the most common type of cholangiocarcinoma, accounting for more than half of all cancers of the bile duct;
  • Distal cholangiocarcinoma;

MORE INFORMATION


PLANS NEW BREATHE

All our services

New Breathe finds the best specialist in your pathology so that you can ask for a second opinion. In addition, it helps you find a clinical trial that meets all the requirements, being able to accompany you and take care of all the bureaucratic part of the process.

MORE INFORMATION


GET THE RIGHT MEDICAL CARE

Book with your doctor

Contact us, ask all your questions and we will help you!

PLANS NEW BREATHE

All our services

New Breathe finds the best specialist in your pathology so that you can ask for a second opinion. In addition, it helps you find a clinical trial that meets all the requirements, being able to accompany you and take care of all the bureaucratic part of the process.


ONE

Plan NewBreathe


Requesting a second opinion, with the best specialist in the area, is now more practical and faster with our support.


LEARN MORE


TWO

Plan NewBreathe +


Getting a second opinion from the best specialist in the field, and additionally finding out if clinical trials are available, will be a simple process with the help of our doctors.


LEARN MORE


THREE

Plan NewBreathe Global


In addition to helping you get a second opinion from the best specialist in the field, and to find out if there are any clinical trials available for your condition, we will walk you through the entire process.


LEARN MORE


New Breathe

WE CARE, WE CAN





New Breathe

WE CARE, WE CAN




0-800-777-2331


24/7 EMERGENCY NUMBER

Call us now if you are in a medical emergency need, we will reply swiftly and provide you with a medical aid.




2021 © New Breathe. Powered with by Goweb Agency.



2021 © New Breath. Powered with by Goweb Agency.